TrialHaematologica2016

Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy.

Marie-Luise Hütter-Krönke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.